12
Views
21
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Rb Inhibits the Intrinsic Kinase Activity of TATA-Binding Protein-Associated Factor TAFII250

&
Pages 846-854 | Received 21 Apr 1998, Accepted 06 Oct 1998, Published online: 28 Mar 2023

REFERENCES

  • Adnane, J., Z. Shao, and J. Robbins 1995. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270:8837–8843.
  • Apone, L. M., C. A. Virbasius, J. C. Reese, and J. Green 1996. Yeast TAFII90 is required for cell cycle progression through G2/M but not for general transcription activation. Genes Dev. 10:2368–2380.
  • Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and J. Kouzarides 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597–601.
  • Bremner, R., B. L. Cohen, M. Spota, P. A. Hamel, C. J. Ingles, B. L. Gallie, and J. Phillips 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:3256–3265.
  • Chen, J.-L., L. D. Attardi, C. P. Verrijzer, K. Yokomori, and J. Tjian 1994. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79:93–105.
  • Chow, K. N. B., and J. Dean 1996. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol. Cell. Biol. 16:4862–4868.
  • Dikstein, R., S. Ruppert, and J. Tjian 1996. TAFII250 is a bipartite protein kinase that phosphorylates the basal transcription factor RAP74. Cell 84:781–790.
  • Dynlacht, B. D. 1997. Regulation of transcription by proteins that control the cell cycle. Nature 389:149–152.
  • Dynlacht, B. D., T. Hoey, and J. Tjian 1991. Coactivators associated with the TATA-binding protein mediate transcriptional activation in Drosophila. Cell 66:563–576.
  • Field, S. J., F. Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin Jr., D. M. Livingston, S. H. Orkin, and J. Greenberg 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549–561.
  • Finkelstein, A., C. F. Kostrub, J. Li, D. P. Chavez, B. Q. Wang, S. M. Fang, J. Greenblatt, and J. Burton 1992. A cDNA encoding RAP74, a general initiation factor for transcription by RNA polymerase II. Nature 355:464–467.
  • Flemington, E. K., S. H. Speck, W. G. Kaelin Jr.. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914–6918.
  • Harlow, E., D. Lane 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • Hayashida, T., T. Sekiguchi, E. Noguchi, H. Sunamoto, T. Ohba, and J. Nishimoto 1994. The CCG1/TAFII250 gene is mutated in thermosensitive G1 mutants of the BHK21 cell line derived from golden hamster. Gene 141:267–270.
  • Helin, K., E. Harlow, and J. Fattaey 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501–6508.
  • Hisatake, K., S. Hasagawa, R. Takada, Y. Nakatani, M. Horikoshi, and J. Roeder 1993. The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1. Nature 362:179–181.
  • Horowitz, J. M., S.-H. Park, E. Bogenmann, J.-C. Cheng, D. W. Yandell, F. J. Kaye, J. D. Minna, T. P. Dryja, and J. Weinberg 1990. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87:2775–2779.
  • Horowitz, J. M., D. W. Yandell, S.-H. Park, S. Canning, P. Whyte, K. Buchkovich, E. Harlow, R. A. Weinberg, and J. Dryja 1989. Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937–940.
  • Kaelin, W. G. Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and J. Flemington 1992. Expression and cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351–364.
  • Kaelin, W. G. Jr., D. C. Pallas, J. A. Decaprio, F. J. Kaye, and J. Livingston 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521–532.
  • Kaye, F. J., R. A. Kratzke, and J. Horowitz 1990. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87:6922–6926.
  • Kim, S.-J., U. S. Onwuta, Y. I. Lee, R. Li, M. R. Botchan, and J. Robbins 1992. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 12:2455–2463.
  • Kim, S. J., H. D. Lee, P. D. Robbins, K. Busam, M. B. Sporn, and J. Roberts 1991. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma susceptibility gene. Proc. Natl. Acad. Sci. USA 88:3052–3056.
  • Lee, J.-O., A. A. Russo, and J. Pavletich 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859–865.
  • Lei, L., D. Ren, A. Finkelstein, and J. Burton 1998. Functions of the N- and C-terminal domains of human RAP74 in transcriptional initiation, elongation, and recycling of RNA polymerase II. Mol. Cell. Biol. 18:2130–2142.
  • Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and J. Harel-Bellan 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–604.
  • Mizzen, C. A., X.-J. Yang, T. Kokubo, J. E. Brownell, A. J. Bannister, T. Owen-Hughes, J. Workman, L. Wang, S. L. Berger, T. Kouzarides, Y. Nakatani, and J. Allis 1996. The TAFII250 subunit of TFIID has histone acetyltransferase activity. Cell 87:1261–1270.
  • Moqtaderi, Z., Y. Bai, D. Poon, P. A. Weil, and J. Struhl 1996. TBP-associated factors are not generally required for transcriptional activation in yeast. Nature 383:188–191.
  • O’Brien, T., and J. Tjian 1998. Functional analysis of the human TAFII250 N-terminal kinase domain. Mol. Cell 1:905–911.
  • Robbins, P. D., J. M. Horowitz, and J. Mulligan 1990. Negative regulation of c-fos expression by the retinoblastoma anti-oncogene. Nature 346:668–671.
  • Ruppert, S., and J. Tjian 1995. Human TAFII250 interacts with RAP74: implications for RNA polymerase II initiation. Genes Dev. 9:2747–2755.
  • Ruppert, S., E. H. Wang, and J. Tjian 1993. Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell cycle regulation. Nature 362:175–179.
  • Rushton, J. J., R. A. Steinman, and J. Robbins 1997. Differential regulation of transcription of p21 and cyclin D1 conferred by TAFII250. Cell Growth Differ. 8:1099–1104.
  • Sekiguchi, T., T. Nakashima, T. Hayashida, A. Kuraoka, S. Hashimoto, N. Tsuchida, Y. Shibata, T. Hunter, and J. Nishimoto 1995. Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor. Exp. Cell Res. 218:490–498.
  • Sellers, W. R., J. W. Rodgers, W. G. Kaelin Jr.. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544–11548.
  • Shan, B., X. Zhu, P.-L. Chen, T. Durfee, Y. Yang, D. Sharp, and J. Lee 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:5620–5631.
  • Shao, Z., S. Ruppert, and J. Robbins 1995. The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250. Proc. Natl. Acad. Sci. USA 92:3115–3119.
  • Shao, Z., J. L. Siegert, S. Ruppert, and J. Robbins 1997. Rb interacts with TAFII250/TFIID through multiple domains. Oncogene 15:385–392.
  • Siegert, J. L., and P. D. Robbins. Unpublished data.
  • Struhl, K. 1997. Selective roles for TATA-binding-protein-associated factors in vivo. Genes Funct. 1:5–9.
  • Suzuki-Yagawa, Y., M. Guermah, and J. Roeder 1997. The ts13 mutation in the TAFII250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature. Mol. Cell. Biol. 17:3284–3294.
  • Tanese, N., B. F. Pugh, and J. Tjian 1991. Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. Genes Dev. 5:2212–2224.
  • Tansey, W. P., and J. Herr 1997. TAFs: guilt by association? Cell 88:729–732.
  • Udvadia, A. J., K. T. Rogers, P. D. R. Higgins, Y. Murata, K. H. Martin, P. A. Humphrey, and J. Horowitz 1993. Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc. Natl. Acad. Sci. USA 90:3265–3269.
  • Walker, S. S., J. C. Reese, L. M. Apone, and J. Green 1996. Transcription activation in cells lacking TAFIIs. Nature 383:185–188.
  • Walker, S. S., W.-C. Shen, J. C. Reese, L. M. Apone, and J. Green 1997. Yeast TAFII145 required for transcription of G1/S cyclin genes and regulated by the cellular growth state. Cell 90:607–614.
  • Weinberg, R. A. 1991. Tumor suppressor genes. Science 254:1138–1146.
  • Weintraub, S. J., K. N. B. Chow, R. X. Luo, S. H. Zhang, S. He, and J. Dean 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812–815.
  • Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and J. Dyson 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537–548.
  • Zwicker, J., N. Liu, K. Engeland, F. Lucibello, and J. Muller 1996. Cell cycle regulation of E2F site occupation in vivo. Science 271:1595–1597.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.